UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

The IL-4/IL-13 signaling axis promotes prostatic fibrosis

PloS one, 2022-10, Vol.17 (10), p.e0275064-e0275064

2022

Volltextzugriff (PDF)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Nature genetics, 2020-10, Vol.52 (10), p.1011-1017

2020

Volltextzugriff (PDF)

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

Cell reports (Cambridge), 2016-10, Vol.17 (4), p.966-976

2016

Volltextzugriff (PDF)

PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues

BMC cancer, 2021-03, Vol.21 (1), p.295-295, Article 295

2021

Volltextzugriff (PDF)

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion

PloS one, 2016-07, Vol.11 (7), p.e0158357-e0158357

2016

Volltextzugriff (PDF)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2

Frontiers in oncology, 2022-11, Vol.12, p.1021845-1021845

2022

Volltextzugriff (PDF)

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis

PloS one, 2012-11, Vol.7 (11), p.e49278-e49278

2012

Volltextzugriff (PDF)

FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer

Nature communications, 2024-06, Vol.15 (1), p.4914-20, Article 4914

2024

Volltextzugriff (PDF)

Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo

The Prostate, 2019-05, Vol.79 (7), p.757-767

2019

Volltextzugriff (PDF)

CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling

PloS one, 2016-07, Vol.11 (7), p.e0159490-e0159490

2016

Volltextzugriff (PDF)

CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer

The Prostate, 2013-05, Vol.73 (6), p.573-581

2013

Volltextzugriff (PDF)

CXCL5 Promotes Prostate Cancer Progression

Neoplasia (New York, N.Y.), 2008-03, Vol.10 (3), p.244-254

2008

Volltextzugriff (PDF)

Causal Inference Engine: a platform for directional gene set enrichment analysis and inference of active transcriptional regulators

Nucleic acids research, 2019-12, Vol.47 (22), p.11563

2019

Volltextzugriff (PDF)

The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia

American journal of clinical and experimental urology, 2023-01, Vol.11 (6), p.467-480

Macoska, Jill A

2023

Volltextzugriff (PDF)

MIM, a Potential Metastasis Suppressor Gene in Bladder Cancer

Neoplasia (New York, N.Y.), 2002-07, Vol.4 (4), p.291-294

2002

Volltextzugriff (PDF)

LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer

Cancer research (Chicago, Ill.), 2023-05, Vol.83 (10), p.1684-1698

2023

Volltextzugriff (PDF)

Prostatic fibrosis, lower urinary tract symptoms, and BPH

Nature reviews. Urology, 2013-09, Vol.10 (9), p.546

2013

Volltextzugriff (PDF)

CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells

The Journal of biological chemistry, 2007-09, Vol.282 (37), p.26767-26774

2007

Volltextzugriff (PDF)

Chemokines and BPH/LUTS

Differentiation (London), 2011-11, Vol.82 (4), p.253-260

Macoska, Jill A.

2011

Volltextzugriff (PDF)

Nanoroughened Surfaces for Efficient Capture of Circulating Tumor Cells without Using Capture Antibodies

ACS nano, 2013-01, Vol.7 (1), p.566-575

2013

Volltextzugriff (PDF)

The IL-4/IL-13 signaling axis promotes prostatic fibrosis

PloS one, 2022-10, Vol.17 (10), p.e0275064

2022

Volltextzugriff (PDF)

TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells

Oncogene, 2019-05, Vol.38 (22), p.4397-4411

2019

Volltextzugriff (PDF)

RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition

Oncogene, 2022-02, Vol.41 (6), p.852-864

2022

Volltextzugriff (PDF)

Androgen receptor variants: another twist in the plot

Oncotarget, 2017-03, Vol.8 (10), p.16100-16100

Macoska, Jill A

2017

Volltextzugriff (PDF)

Forkhead domain mutations in FOXA1 drive prostate cancer progression

Cell research, 2019-09, Vol.29 (9), p.770-772

2019

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(122)
Dissertationen
(1)

Sprache

Englisch
(123)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(16)
Cancer Research
(15)
The Prostate
(12)
Neoplasia
(7)
The prostate/the prostate
(7)
The journal Of Urology/the journal Of Urology
(6)
Genes Chromosomes & Cancer
(5)
Plos One
(5)
The American Journal Of Pathology
(4)
Urology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The IL-4/IL-13 signaling axis promotes prostatic fibrosis

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis

FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer

Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo

CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling

CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer

CXCL5 Promotes Prostate Cancer Progression

Causal Inference Engine: a platform for directional gene set enrichment analysis and inference of active transcriptional regulators

The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia

MIM, a Potential Metastasis Suppressor Gene in Bladder Cancer

LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer

Prostatic fibrosis, lower urinary tract symptoms, and BPH

CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells

Chemokines and BPH/LUTS

Nanoroughened Surfaces for Efficient Capture of Circulating Tumor Cells without Using Capture Antibodies

The IL-4/IL-13 signaling axis promotes prostatic fibrosis

TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells

RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition

Androgen receptor variants: another twist in the plot

Forkhead domain mutations in FOXA1 drive prostate cancer progression

Suchergebnisse filtern